Please use this identifier to cite or link to this item:
https://doi.org/10.1155/2015/219012
Title: | Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? | Authors: | Wong, A Ngeow, J |
Keywords: | BRCA1 protein BRCA2 protein cancer epidemiology cancer patient cancer risk Cowden syndrome endometrium carcinoma female gene gene mutation hereditary nonpolyposis colorectal cancer human immunohistochemistry laboratory test meta analysis (topic) mismatch repair Muir Torre syndrome multicenter study (topic) mutational analysis oncogene ovary carcinoma polymerase chain reaction PTEN gene Review risk assessment Colorectal Neoplasms, Hereditary Nonpolyposis Endometrial Neoplasms Hamartoma Syndrome, Multiple Muir-Torre Syndrome pathology risk assessment Colorectal Neoplasms, Hereditary Nonpolyposis DNA Mismatch Repair Endometrial Neoplasms Female Hamartoma Syndrome, Multiple Humans Muir-Torre Syndrome Risk Assessment |
Issue Date: | 2015 | Citation: | Wong, A, Ngeow, J (2015). Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?. BioMed Research International 2015 : 219012. ScholarBank@NUS Repository. https://doi.org/10.1155/2015/219012 | Rights: | Attribution 4.0 International | Abstract: | Endometrial carcinoma is the most common gynecological tumor worldwide. It can be the presenting malignancy, acting as the harbinger, of an undiagnosed hereditary syndrome. Up to 50% of females with Lynch syndrome present in this manner. Differentiation between Lynch, Muir-Torre, and Cowden syndromes can at times be challenging due to the overlapping features. Our review emphasizes on the strengths, pitfalls, and limitations of microscopic features as well as immunohistochemical and polymerase chain reaction- (PCR-) based tests used by laboratories to screen for DNA mismatch repair (MMR) and PTEN gene mutations in patients to enable a more targeted and cost effective approach in the use of confirmatory gene mutational analysis tests. This is crucial towards initiating timely and appropriate surveillance measures for the patient and affected family members. We also review the evidence postulating on the possible inclusion of uterine serous carcinoma as part of the spectrum of malignancies seen in hereditary breast and ovarian carcinoma syndrome, driven by mutations in BRCA1/2. © 2015 Adele Wong and Joanne Ngeow. | Source Title: | BioMed Research International | URI: | https://scholarbank.nus.edu.sg/handle/10635/183610 | ISSN: | 23146133 | DOI: | 10.1155/2015/219012 | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1155_2015_219012.pdf | 1.39 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License